<DOC>
	<DOCNO>NCT01450878</DOCNO>
	<brief_summary>Background : Numerous study outline cellular pleiotropic effect erythropoietin ( EPO ) role prevention ischemic-reperfusion lesion acute ischemic injury brain heart . However , study carry animal model definitive proof exists today demonstrate EPO similar beneficial effect human pathology . Purpose : The aim study demonstrate human , EPO protect ischemic-reperfusion lesion model ischemia i.e . kidney transplantation .</brief_summary>
	<brief_title>Renal Graft Function After Treatment With Erythropoietin ( EPO )</brief_title>
	<detailed_description>Abstract : Since discovery EPO receptor express various tissue , numerous study demonstrate EPO involved erythropoiesis also exert pleiotropic effect cell . Among , one excite role prevention ischemic-reperfusion lesion acute ischemic injury brain heart . However , study carry animal model definitive proof exists today demonstrate EPO similar beneficial effect human pathology . Kidney transplantation one ischemic situation EPO pleiotropic effect could great interest since ischemic-reperfusion lesion involve delayed graft function impair graft outcome . The aim prospective randomize double blind study assess effect 100 000 UI béta-epoiétin kidney graft function , give decease donor one hour retreaval organ . Recipients follow three month order evaluate kidney function ( glomerular filtration rate ) number acute rejection episode determine whether beta-epoietin could modify immunogenicity graft .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>donor : cadaveric organ donor , age ≥ 18 year , monoorgan ( kidney ) retrieval , retrieval do centre Limoges , Bordeaux , Toulouse , Angers , Brest , Nantes , Poitiers , Rennes , Tours , hematocrit ≤ 45 % . Recipient : age ≥ 18 year , wait list kidney graft . living donor , age 18 year , multiorgan retrieval , donor hematocrit 45 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>high dose EPO</keyword>
	<keyword>transplant kidney</keyword>
	<keyword>cadaveric organ donor</keyword>
	<keyword>mono-organ ( kidney ) retrieval</keyword>
	<keyword>patient</keyword>
	<keyword>kidney graft</keyword>
</DOC>